Nonprofits›Nationwide Childrens Hospital Inc
Medical Research
Nationwide Childrens Hospital Inc
COLUMBUS, OH
Total revenue
—
Total expenses
—
Net assets
—
Grants received
$417.2M
357 grants
EIN
316056230
Tax year
—
Grants received
Showing 200 of 357
FromAmountPurposeYear
$325K
Raise awareness and support research and treatment of childhood cancer.
2024
$200K
TO FUND RESEARCH TO ADVANCE TREATMENT OPTIONS FOR CONGENITAL HEART DISEASE
2024
$149K
TO CURE CHILDREN AND IMPROVE CAPACITY AND QUALITY OF TREATMENT
2024
$36K
$31,455 of this grant supported optimizing the experimental gene therapy vector for PGAP3-CDG and testing it in patient induced neuron cell lines, as well as testing several small molecule potential therapies on those advanced cell lines. $5000 of this grant went to licensing the IP for all research completed at Nationwide Children's Hospital to Moonshots for Unicorns, as the principal investigator involved in this research left the institution. This enabled us to continue the research and advance its progress toward a clinical trial at other institutions.
2024
$1.6M
TO CURE CHILDREN AND IMPROVE CAPACITY AND QUALITY OF TREATMENT
2023
$325K
Raise awareness and support research and treatment of childhood cancer.
2023
$100K
Raise awareness and support research and treatment of childhood cancer.
2023
$62K
This grant supported research aimed at creating an effective gene therapy to cure the monogenic disorder PGAP3-CDG, including testing it on mice and patient cells.
2023
$9K
THE PURPOSE OF THE STUDY IS TO LEARN ABOUT HOW VCP DISEASE CHANGES PEOPLE'S STRENGTH AND MOVEMENTS AND AFFECTS THEIR DAILY LIFE. THIS INFORMATION WILL HELP IMPROVE CARE. IT WILL ALSO HELP RESEARCHERS PLAN AND DESIGN FUTURE RESEARCH STUDIES TO HELP THOSE WITH VCP DISEASE.
2023
$987K
TO CURE CHILDREN AND IMPROVE CAPACITY AND QUALITY OF TREATMENT
2022
$200K
Raise awareness and support research and treatment of childhood cancer.
2022
$126K
This grant was made to support research aimed a creating an effective gene therapy to cure the monogenic disorder PGAP3-CDG.
2022
$53K
THE PURPOSE OF THE STUDY IS TO LEARN ABOUT HOW VCP DISEASE CHANGES PEOPLE'S STRENGTH AND MOVEMENTS AND AFFECTS THEIR DAILY LIFE. THIS INFORMATION WILL HELP IMPROVE CARE. IT WILL ALSO HELP RESEARCHERS PLAN AND DESIGN FUTURE RESEARCH STUDIES TO HELP THOSE WITH VCP DISEASE.
2022
$35K
CARE PROGRAM- AWARD FOR MAINTAINING PPMD CERTIFIED DUCHENNE CARE CENTER STANDARDS
2022
$436K
PEDIATRIC MEDICAL RESEARCH GRANT SUBAWARD AND AWARD FOR HIRSCHSPRUNG DISEASE RESEARCH PROJECT
2021
$80K
THE PURPOSE OF THE STUDY IS TO LEARN ABOUT HOW VCP DISEASE CHANGES PEOPLE'S STRENGTH AND MOVEMENTS AND AFFECTS THEIR DAILY LIFE. THIS INFORMATION WILL HELP IMPROVE CARE. IT WILL ALSO HELP RESEARCHERS PLAN AND DESIGN FUTURE RESEARCH STUDIES TO HELP THOSE WITH VCP DISEASE.
2021
Funded by
$417.2M from 99 funders · 357 grants · 2017–2024
Nationwide Childrens Hospital Group Return
$351.6M · 16 grants · 2020–2024
Cystic Fibrosis Foundation
$9.1M · 42 grants · 2018–2024
Jobsohio
$8.5M · 3 grants · 2021–2023
American Heart Association Inc
$5.1M · 5 grants · 2018–2023
The Children's Hospital Of Philadelphia
$4.6M · 6 grants · 2017–2023
The Children's Oncology Group
$3.9M · 4 grants · 2020–2024
Johns Hopkins University
$2.7M · 6 grants · 2017–2023
Alexs Lemonade Stand Foundation
$2.6M · 7 grants · 2018–2024
Details
EIN316056230
NTEE codeH980
Subsection03
Ruling date2003-10